HIV and Pregnancy — Protecting Yourself and Your Baby

First, take a breath. An HIV diagnosis during pregnancy can feel overwhelming, but the medical reality is far more hopeful than most people expect. With consistent antiretroviral therapy (ART) and proper medical care, the risk of transmitting HIV to your baby — called perinatal or vertical transmission — drops to less than 1%. Without treatment, the risk is 15-45%, so the difference that treatment makes is extraordinary.

Transmission can happen during pregnancy (virus crossing the placenta), during labor and delivery (contact with blood and fluids), or during breastfeeding. ART works by suppressing the virus to undetectable levels in your blood, which dramatically reduces the amount of virus your baby is exposed to at every stage.

An undetectable viral load — meaning fewer than 200 copies of HIV per milliliter of blood — is the single most important factor in preventing transmission. This is why starting or continuing ART as early as possible in pregnancy is so critical. Most women who are already on ART before pregnancy simply continue their regimen (with possible adjustments for pregnancy safety), while those newly diagnosed are started on treatment immediately.

Your baby is not born with a predetermined outcome. With modern medicine, the vast majority of babies born to HIV-positive mothers are HIV-negative. You can have a healthy pregnancy, a healthy delivery, and a healthy baby.

HIV testing is a routine part of prenatal care in most countries, and the CDC and ACOG both recommend that all pregnant people be tested for HIV at the first prenatal visit, regardless of perceived risk. This is opt-out screening — meaning it's included in your standard prenatal blood work unless you specifically decline it. The goal is universal screening, not targeted testing, because HIV doesn't discriminate by demographics.

The standard screening test is a fourth-generation antigen/antibody test, which detects both HIV antibodies and the p24 antigen. This test can identify HIV infection as early as 2-4 weeks after exposure, making it highly accurate. If the initial screen is positive, a confirmatory test (typically a differentiation assay) is performed before a diagnosis is made.

Retesting in the third trimester (around 28-32 weeks) is recommended for people who are at higher risk — including those with a new sexual partner during pregnancy, those in areas with high HIV prevalence, those with other sexually transmitted infections, or those who use injection drugs. Some states mandate third-trimester retesting for all pregnant people.

If you arrive at labor and delivery without documented HIV testing during pregnancy, a rapid HIV test should be performed. Rapid tests provide results in 20-60 minutes, allowing immediate decisions about intrapartum prophylaxis if needed.

Knowing your status early gives you the best chance of protecting your baby. If you're unsure whether HIV testing was included in your prenatal labs, ask your provider directly.

Antiretroviral therapy (ART) is the cornerstone of preventing mother-to-child transmission, and it is safe during pregnancy. ART involves taking a combination of HIV medications daily — typically two or three drugs from different classes — to suppress the virus to undetectable levels.

If you're newly diagnosed during pregnancy, your provider will start ART as soon as possible. The specific regimen depends on your health, viral load, resistance testing, and how far along you are. Commonly recommended regimens include integrase strand transfer inhibitors (like dolutegravir) combined with two nucleoside reverse transcriptase inhibitors (like tenofovir/emtricitabine or abacavir/lamivudine). Dolutegravir-based regimens are now recommended by the WHO as the preferred first-line treatment, including during pregnancy, based on strong safety and efficacy data.

If you were already on ART before becoming pregnant, do not stop your medications. Contact your provider to review your regimen — some adjustments may be needed, but uninterrupted viral suppression is the priority. Stopping ART risks viral rebound, which increases transmission risk.

Adherence is everything. Taking your medication consistently, every day, at the recommended times is the most important thing you can do for your baby. Even a few missed doses can allow the virus to rebound. If you're struggling with side effects, pill fatigue, or access to medication, tell your provider — there are almost always alternatives and support programs available.

ART during pregnancy has been extensively studied. The medications do cross the placenta, but decades of data from large registries (like the Antiretroviral Pregnancy Registry) have shown that most ART drugs do not increase the risk of birth defects. The benefit of preventing HIV transmission far outweighs theoretical risks.

This is one of the most emotionally charged questions for HIV-positive mothers, and the answer has evolved significantly with improved treatment. The honest answer is: it depends on your situation, your viral load, and your setting — and both choices are valid.

Historically, in high-resource settings like the United States, exclusive formula feeding was recommended to eliminate any residual risk of transmission through breast milk. This is still the position of organizations like the AAP and, until recently, most U.S. guidelines. However, this guidance is shifting.

The WHO recommends that mothers living with HIV who are on ART with sustained viral suppression breastfeed for at least 12 months (and up to 24 months), particularly in settings where clean water, formula access, and infant mortality from other causes are concerns. Research has shown that with consistent ART and an undetectable viral load, the risk of transmission through breastfeeding is very low — estimated at less than 1% over 12 months.

In 2023, updated NIH guidelines in the U.S. acknowledged that for people on ART with sustained undetectable viral loads, breastfeeding can be supported with shared decision-making between the patient and provider. This marked a significant shift from blanket recommendations against breastfeeding.

What matters most: your viral load must be consistently undetectable, you must be adherent to ART throughout the breastfeeding period, and your baby should be monitored. Mixed feeding (breast milk plus formula) may carry slightly higher risk than exclusive breastfeeding due to potential gut inflammation in the infant.

Whatever you choose, it's the right choice for you. Formula feeding is a safe, loving way to nourish your baby. Breastfeeding, when medically supported, is also a safe, loving choice. No one should shame you for either decision.

Protection starts well before delivery and continues for the first months of your baby's life. Here's what to expect at each stage.

During pregnancy: the most important protection is maintaining an undetectable viral load through consistent ART. Your viral load will be checked regularly — typically at the start of treatment, 2-4 weeks after starting or changing medications, monthly until undetectable, and then at least every 1-3 months throughout pregnancy.

During labor and delivery: if your viral load is undetectable (below 50 copies/mL) near delivery, vaginal birth is safe and recommended — there's no added benefit from cesarean section for HIV prevention alone. If your viral load is above 1,000 copies/mL near the time of delivery, a scheduled cesarean at 38 weeks is recommended to reduce exposure. If your viral load is between 50 and 999, the decision is individualized. Intravenous zidovudine (AZT) during labor is recommended for people with viral loads above 50 copies/mL.

After birth: your baby will receive prophylactic antiretroviral medication — typically zidovudine syrup for 4-6 weeks. In higher-risk situations (high maternal viral load, late or no prenatal ART), a combination of antiretrovirals may be given to the infant.

Testing your baby: standard antibody tests don't work for infants because maternal antibodies cross the placenta. Instead, HIV DNA or RNA PCR (virologic) tests are used, typically at 14-21 days, 1-2 months, and 4-6 months of age. Two negative virologic tests — one at 1 month or older and one at 4 months or older — generally confirm the baby is HIV-negative. A confirmatory antibody test at 18 months ensures maternal antibodies have cleared.

Learning your partner's HIV status during pregnancy brings up fear, confusion, and sometimes feelings of betrayal. Whatever you're feeling is valid. Here's what you need to know medically.

First, get tested immediately if you haven't been already. If your most recent test was negative, your provider may recommend repeat testing, including an RNA (viral load) test that can detect very recent infection before antibodies develop.

If you test negative and your partner is HIV-positive, you are in a serodiscordant relationship. This is more common than most people realize, and with the right precautions, you can stay negative throughout pregnancy and beyond.

PrE-exposure prophylaxis (PrEP) is a daily medication (typically tenofovir/emtricitabine) that is over 99% effective at preventing HIV acquisition when taken consistently. PrEP is safe during pregnancy — both the WHO and CDC support its use for pregnant people at substantial risk of HIV. If your partner is on ART with an undetectable viral load, the risk of sexual transmission is effectively zero (this is the U=U principle: Undetectable = Untransmittable), but PrEP provides an additional layer of protection and peace of mind.

Couples counseling with an HIV-experienced provider can help navigate the emotional complexity — disclosure, trust, sexual health, and planning for the baby's safety. Many HIV clinics offer couples testing and counseling as a standard service.

Practical steps: ensure your partner is on ART and achieving viral suppression, discuss PrEP with your OB or an HIV provider, use condoms as an additional barrier if desired, and get retested for HIV in your third trimester and at delivery. Your emotional well-being matters too — seek support from a therapist, counselor, or peer support group if you need it.

Living with HIV during pregnancy can feel isolating, but you are not alone — and excellent resources exist to help with medical care, emotional support, financial assistance, and connecting with others who understand.

The HRSA Ryan White HIV/AIDS Program is the largest federal program dedicated to HIV care. It provides medical care, medications, and support services for people living with HIV who are uninsured or underinsured. Services include access to ART and other medications through the AIDS Drug Assistance Program (ADAP), case management, transportation to medical appointments, mental health services, and nutrition support. You can find your nearest Ryan White-funded provider at findhivcare.hrsa.gov.

Local AIDS Service Organizations (ASOs) provide community-based support including peer counseling, support groups (some specifically for pregnant women and new mothers living with HIV), assistance with housing, food, and other basic needs, help navigating insurance and benefits, and legal advocacy.

National resources include the CDC's HIV information line (1-800-232-4636), the National Perinatal HIV Hotline (1-888-448-8765) staffed by clinicians who specialize in HIV and pregnancy, AIDSinfo (hivinfo.nih.gov) for treatment guidelines and clinical trial information, and The Well Project (thewellproject.org), which is specifically for women living with HIV and includes personal stories, fact sheets, and community forums.

Peer support can be transformative. Connecting with other HIV-positive mothers — through support groups, online communities, or organizations like The Well Project or Positive Women's Network — can reduce stigma, provide practical advice, and remind you that a fulfilling life with HIV is not only possible but common.

You deserve compassionate, non-judgmental care. If you ever feel stigmatized by a healthcare provider, you have the right to seek care elsewhere.